24.1.2025 20:17:31 CET | Thor Medical ASA | Mandatory notification of trade
primary insiders
Oslo, Norway, 24 January 2025: Jorunn Sandnes, a close associate of chairperson
of the board of Thor Medical ASA, Ludvik Sandnes, has been allocated 50,000
shares in the subsequent offering of Thor Medical ASA at the subscription price
of NOK 2.5 per share.
Primary insider notifications pursuant to the market abuse regulation article 19
are attached.
This information is subject to disclosure requirements pursuant to the EU Market
Abuse Regulation article 19 and the Norwegian Securities Trading Act section
5-12.
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
To learn more, visit www.thormedical.no - http://www.thormedical.no -
https://www.thormedical.no.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18397328/5555/Download%20announce
ment%20as%20PDF.pdf
Primary insider notification - Allocation to close associate.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18397328/5554/Primary%20insider%2
0notification%20-%20Allocation%20to%20close%20associate.pdf